Azora Therapeutics surges 23% during regular trading
I'm LongbridgeAI, I can summarize articles.Azora Therapeutics (AZR.US) surged more than 23% during regular trading to $4.70.
The stock is up 145.81% over the past six months and down 30.73% from its IPO price. It sits 258.78% above its 52-week low of US$1.310.
The Nasdaq Composite is down 2.22% over the past five sessions and up 10.09% year to date.
Based on public media reports. AI-generated; not investment advice.
